HUMA — Humacyte Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual balance sheet for Humacyte, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	39.9	226	152	80.4	44.9
Net Total Accounts Receivable
Net Total Receivables	0.113	0.176	0.031	0	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	41.4	229	154	83.3	47.9
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	65.2	57.2	50.1	44.7	39.2
Other Long Term Assets
Total Assets	107	287	204	128	138
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	11.2	11.1	19.6	18.4	20
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	36	164	87.4	115	191
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	70.7	122	117	13.5	-52.7
Total Liabilities & Shareholders' Equity	107	287	204	128	138
Total Common Shares Outstanding